logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Margarita Romeo

IGTP
H指数:21
被引数:2,010

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors

双链断裂的增加使肿瘤对氧化代谢抑制剂更敏感。

Biomedicine & Pharmacotherapy
IF7.5
2026-03-100
OAAI
Ferran Medina-Jover; Agnès Figueras; Núria Gendrau-Sanclemente; Emilio Racionero-Andrés; Meritxell Sociats-Font; Álvaro Lahiguera; Pau Guillén; María Tormo-Fabios; Roderic Espín; Miguel Ángel Pardo-Cea; Andrés Mendez-Lucas; Edurne Berra; Josep Maria Piulats; Álvaro Aytés; Alberto Villanueva; Adrià Bernat-Peguera; Margarita Romeo; Miquel Angel Pujana; José Carlos Perales; Francesc Viñals
Addressing unmet needs in long-term survivors of ovarian cancer (ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI): insights from a Spanish cohort

探讨卵巢癌长期生存者中未满足需求的研究（ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI）：来自西班牙队列的见解

International Journal of Gynecological Cancer
IF4.7
2026-01-070
PRE
Maria-Pilar Barretina-Ginesta; Ainhoa Madariaga; Marta Gil-Martín; Avinash Ramchandani; Marta Pardo; Ana Beatriz Sanchez-Heras; Cristina Churruca; Eva Maria Guerra-Alia; Caterina Madroñal; Julen Fernandez-Plana; Ana Herrero; Emma Dotor; Carmen Esteban; María Quindós-Varela; Margarita Romeo; Ester Gost; María José Bermejo; Concepción Fernandez-Chacón; Neus Ferrer; Cesar Gomez-Raposo
Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status

含体细胞或胚系BRCA和同源重组修复突变状态的铂敏感复发卵巢癌患者接受奥拉帕利维持治疗后的总生存期

BRITISH JOURNAL OF CANCER
IF6.8
2025-03-170
OA
Pignata, Sandro; Oza, Amit; Hall, Geoff; Pardo, Beatriz; Madry, Radoslaw; Cibula, David; Klat, Jaroslav; Montes, Ana; Glasspool, Rosalind; Colombo, Nicoletta; Pete, Imre; Herrero Ibanez, Ana; Romeo, Margarita; Ilieva, Rumyana; Timcheva, Constanta; Di Maio, Massimo; Bashir, Zahid; Taylor, Rosie; Barnicle, Alan; Clamp, Andrew
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-10-230
OAAI
Pous, Anna; Bernat-Peguera, Adria; Lopez-Paradis, Assumpcio; Cirauqui, Beatriz; Quiroga, Vanesa; Teruel, Iris; Felip, Eudald; Ferrando-Diez, Angelica; Bergamino, Milana; Boronat, Laia; Romeo, Margarita; Soler, Gemma; Marino, Christian; Rodriguez-Martinez, Paula; Pons, Laura; Ballana, Ester; Martinez-Cardus, Anna; Margeli, Mireia
A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer (vol 24, 876, 2024)
BMC CANCER
IF3.4
2024-07-290
OAAI
Leary, Alexandra; Estevez-Garcia, Purificacion; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina-Ginesta, Pilar; Gil-Martin, Marta; Garralda, Elena; Bosch-Barrera, Joaquim; Moran, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascon, Pere; Rodon, Jordi; Lizcano, Jose M.; Munoz-Guardiola, Pau; Fierro-Duran, Gemma; Pedros-Gamez, Oriol; Perez-Montoyo, Hector; Yeste-Velasco, Marc; Cortal, Marc; Perez-Campos, Antonio; Alfon, Jose; Domenech, Carles; Perez-Fidalgo, Alejandro; Oaknin, Ana
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
BMC CANCER
IF3.4
2024-07-223
OAAI
Leary, Alexandra; Estevez-Garcia, Purificacion; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina-Ginesta, Pilar; Gil-Martin, Marta; Garralda, Elena; Bosch-Barrera, Joaquim; Moran, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascon, Pere; Rodon, Jordi; Lizcano, Jose M.; Munoz-Guardiola, Pau; Fierro-Duran, Gemma; Pedros-Gamez, Oriol; Perez-Montoyo, Hector; Yeste-Velasco, Marc; Cortal, Marc; Perez-Campos, Antonio; Alfon, Jose; Domenech, Carles; Perez-Fidalgo, Alejandro; Oaknin, Ana
Phase 1 evaluation of triple therapy with boserolimab (anti-CD27 agonist), pembrolizumab, and chemotherapy in patients with triple-negative breast cancer (TNBC) with PD-L1 combined positive score (CPS) <10: Safety, antitumor activity, and association between biomarkers and response
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Rojas, Carlos; de Speville, Bernard Gaston Doger; Im, Seock-Ah; Shapira-Frommer, Ronnie; De Miguel, Maria; Cortijo, Lucia Gonzalez; Marin, Margarita Romeo; de Jonge, Maja; Ayers, Mark; Zhang, Yiwei; Zhai, Song; Chartash, Elliot; Dobrenkov, Konstantin; Sohn, Joohyuk
A phase II trial of avelumab in combination with pegylated liposomal doxorubicin in recurrent/metastatic endometrial cancer (GEICO 70-E): analysis according to molecular classification
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Piulats Rodriguez, J. M.; Palacio Vazquez, I.; Alarcon, J. D.; Gatius, S.; Marin Jimenez, J. A.; Gil Martin, M.; Marquez Aragones, A.; Santacana, M.; Manso Sanchez, L. M.; Hernando Polo, S.; Ruiz, N.; Matias-Guiu, X.; Romeo Marin, M.; Navarro Garces, V.; Barbarroja, P.
Atezolizumab (atezo) combined with platinum-based chemotherapy (CT) and maintenance niraparib for recurrent ovarian cancer (rOC) with a platinum-free interval (TFIp) >6 months: Primary analysis of the double-blind placebo (pbo)controlled ENGOT-Ov41/GEICO 69-O/ANITA phase III trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-012
PRE
Martin, A. Gonzalez; Perez, M. J. Rubio; Heitz, F.; Christensen, R. D.; Colombo, N.; Van Gorp, T.; Oaknin, A.; Leary, A.; Garcia, L. Gaba; Lebreton, C.; Gonzalez, L. M. De Sande; Marin, M. Romeo; Redondo, A.; Ginesta, M. P. Barretina; Fidalgo, J. A. Perez; Bertran, A. Santaballa; Bermejo-Perez, M. J.; Bruchim, I.; Ray-Coquard, I. L.; Selle, F.
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
OBSTETRICAL & GYNECOLOGICAL SURVEY
IF3.6
2023-06-013
OA
Matulonis, Ursula A.; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Dean, Andrew; Denys, Hannelore; Colombo, Nicoletta; Van Gorp, Toon; Konner, Jason A.; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth G.; Wang, Jiuzhou; Noble, Elizabeth; Esteves, Brooke; Method, Michael; Coleman, Robert L.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
BRITISH JOURNAL OF CANCER
IF6.8
2023-02-0915
OAAI
Colombo, N.; Gadducci, A.; Sehouli, J.; Rulli, E.; Maenpaa, J.; Sessa, C.; Montes, A.; Ottevanger, N. B.; Berger, R.; Vergote, I.; D'Incalci, M.; Galaz, C. Churruca; Chekerov, R.; Nyvang, G. B.; Riniker, S.; Herbertson, R.; Fossati, R.; Barretina-Ginesta, M. P.; Deryal, M.; Mirza, M. R.; Biagioli, E.; Iglesias, M.; Funari, G.; Romeo, M.; Tasca, G.; Pardo, B.; Tognon, G.; Rubio-Perez, M. J.; DeCensi, A.; De Giorgi, U.; Zola, P.; Panici, P. Benedetti; Aglietta, M.; Arcangeli, V.; Zamagni, C.; Bologna, A.; Westermann, A.; Heinzelmann-Schwarz, V.; Tsibulak, I.; Wimberger, P.; Poveda, A.
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors

化疗和/或免疫治疗对实体瘤患者SARS-CoV-2 mRNA-1237疫苗中和抗体反应的影响

MOLECULAR ONCOLOGY
IF4.5
2022-12-305
OA
Felip, Eudald; Pradenas, Edwards; Romeo, Margarita; Marfil, Silvia; Trinite, Benjamin; Urrea, Victor; Hernandez, Ainhoa; Ballana, Ester; Cucurull, Marc; Mateu, Lourdes; Massanella, Marta; Clotet, Bonaventura; Moran, Teresa; Blanco, Julia
Aurora kinase overexpression may play a role in PARPi resistance in tumor samples of patients with high grade ovarian cancer and its inhibition with alisertib overcomes resistance to olaparib in a PARPi-resistant cell line model
ANNALS OF ONCOLOGY
IF65.4
2022-09-010
OAAI
Perez Fidalgo, J. A.; Martinez Pretel, J. J.; Heredia, V.; Romeo Marin, M.; Mendiola, M.; Hochstadt, J.; Bernat, A.; Sanchez-Serrano, P.; Redondo Sanchez, A.; Gil Martin, M.; Guerra Ojeda, S.; Teruel, I.; Burgues, O.; Cervantes, A.; Pineda Merlo, B.

研究方向

暂未获取到该数据
M
Mireia Margelí Vila
H 指数:31论文数:428被引数:3,611
E
Eudald Felip
H 指数:20论文数:113被引数:1,596
B
Beatriz Cirauqui
H 指数:20论文数:133被引数:1,850
A
Ana Oaknin
H 指数:71论文数:715被引数:3.6万
I
Iris Teruel
H 指数:7论文数:49被引数:171
M
Marta Gil-Martín
H 指数:28论文数:232被引数:5,583
E
Ester Ballana
H 指数:34论文数:143被引数:4,916
J
José Alejandro Pérez Fidalgo
H 指数:40论文数:392被引数:6,974
A
Adrià Bernat‐Peguera
H 指数:9论文数:39被引数:487
A
Alexandra Léary
H 指数:62论文数:715被引数:2.4万